3970-79-4 Usage
Uses
Used in Pharmaceutical Industry:
1-Oxa-8-azaspiro[4.5]decane, hydrochloride serves as a pharmaceutical intermediate for the synthesis of various medications, playing a crucial role in the development of new drugs.
1-Oxa-8-azaspiro[4.5]decane, hydrochloride is used as a building block in organic synthesis for the preparation of complex organic molecules, which can be integral to the creation of innovative pharmaceutical compounds.
Used in Organic Synthesis:
1-Oxa-8-azaspiro[4.5]decane, hydrochloride is utilized as a key component in the synthesis of complex organic molecules, contributing to the advancement of organic chemistry and the development of new chemical entities.
Used in Specialty Chemicals Production:
1-Oxa-8-azaspiro[4.5]decane, hydrochloride may be employed in the production of specialty chemicals, indicating its versatility beyond the pharmaceutical domain and into broader industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 3970-79-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,9,7 and 0 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 3970-79:
(6*3)+(5*9)+(4*7)+(3*0)+(2*7)+(1*9)=114
114 % 10 = 4
So 3970-79-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H15NO.ClH/c1-2-8(10-7-1)3-5-9-6-4-8;/h9H,1-7H2;1H
3970-79-4Relevant academic research and scientific papers
TETRAHYDROPYRAN COMPOUNDS AS TACHYKININ ANTAGONISTS
-
Page 78, (2010/02/08)
The present invention relates to the compounds of the formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9 and W are as defined herein, and pharmaceutically acceptable salts thereof; the compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis or postherpetic neuralgia.
Cyclohexane derivatives and their use as therapeutic agents
-
Page 29, (2010/02/06)
The present invention relates compounds of formula (I), wherein ring A is a phenyl or pyridyl ring; X represents a linker selected from the group consisting of formulae: (a), (b), (c), (d), and (e); and R1, R2, R3, R4, R5, R6, R7, R13, R14, R15, R16, R17, R21a and R21b are as defined herein. The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis or postherpetic neuralgia.
